Sign Up to like & get
recommendations!
0
Published in 2025 at "NPJ Vaccines"
DOI: 10.1038/s41541-025-01132-x
Abstract: The clinical response to immune checkpoint blockade (ICB) is limited in the majority of patients with colorectal cancer. These immune checkpoint proteins may not only inhibit T-cell-mediated antitumor immunity but also attenuate antigen presentation, including…
read more here.
Keywords:
cancer;
based cancer;
response;
efficacy neoantigen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Chemical Society reviews"
DOI: 10.1039/d3cs00162h
Abstract: Neoantigens play a pivotal role in the field of tumour therapy, encompassing the stimulation of anti-tumour immune response and the enhancement of tumour targeting capability. Nonetheless, numerous factors directly influence the effectiveness of neoantigens in…
read more here.
Keywords:
cancer theranostics;
advancing nanotechnology;
nanotechnology;
neoantigen based ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e20674
Abstract: e20674 Background: DC vaccine is a promising strategy for cancer therapy. We conducts a personalized, neoantigen-loaded DC therapy trial in advanced NSCLC (NCT02956551 & ChiCTR-ONC-16009100). Here we provide the updated data. Methods: Advanced lung cancer…
read more here.
Keywords:
neoantigen based;
based personalized;
lung cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e14513
Abstract: e14513 Background: Local recurrence of Hepatocellular Carcinoma (HCC) following potentially curative resection or ablation is an inevitable risk. T cells recognizing neoantigens are present in most cancers including HCC and offer a specific and highly…
read more here.
Keywords:
based mrna;
neoantigen;
ablation;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2025.1614228
Abstract: The cancer genomic instability drives the generation of neoantigens, making them ideal targets for immunotherapy. Neoantigen-specific tumor-infiltrating lymphocytes achieve precise tumor cell killing by recognizing neoantigens on the tumor surface, but their efficacy is limited…
read more here.
Keywords:
physical barriers;
neoantigen;
based therapies;
tumor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancers"
DOI: 10.3390/cancers17121953
Abstract: Simple Summary Lung cancer, a leading malignancy with delayed diagnosis and poor prognosis. Neoantigen-based immunotherapy has emerged as a precision strategy, targeting tumor-specific antigens generated by somatic mutations. Unlike tumor-associated antigens, neoantigens are exclusive to…
read more here.
Keywords:
lung cancer;
neoantigen based;
tumor;
lung ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16030392
Abstract: Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens,…
read more here.
Keywords:
current trends;
based cancer;
cancer vaccines;
neoantigen based ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10020196
Abstract: Alternatives to conventional cancer treatments are highly sought after for high-risk malignancies that have a poor response to established treatment modalities. With research advancing rapidly in the past decade, neoantigen-based immunotherapeutic approaches represent an effective…
read more here.
Keywords:
cancer;
optimization;
neoantigen based;
neoantigen ... See more keywords